Item 8.01. Other Events.
On January 28, 2021, Seelos Therapeutics, Inc. (the "Company") issued a press
release announcing the closing of its previously announced underwritten public
offering of shares of its common stock. In the offering, the Company sold an
aggregate of 17,530,488 shares of its common stock at a public offering price of
$2.05 per share, which includes the exercise in full by the underwriter of its
option to purchase up to 2,286,585 additional shares of common stock. A copy of
the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K
and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Number Description
99.1 Press Release, dated January 28, 2021.
* * *
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses